PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9537825-0	1997	Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson"s disease, does not impair mitochondrial energy production.	entacapone	0-10	catechol-O-methyltransferase	Mus musculus	20-48	
9537825-8	1997	These results show that peripherally acting entacapone, unlike the brain-penetrating tolcapone, is a safe catechol-O-methyltransferase inhibitor for the treatment of Parkinson"s disease, since it does not interfere with mitochondrial energy metabolism at pharmacologically effective concentrations.	entacapone	44-54	catechol-O-methyltransferase	Mus musculus	106-134	
33269743-1	2021	Entacapone, a catechol-O-methyltransferase inhibitor, can strengthen the therapeutic effects of levodopa on the treatment of Parkinson"s disease.	entacapone	0-10	catechol-O-methyltransferase	Mus musculus	14-42